https://www.fiercebiotech.com/biote...h-a-1b-deal-for-heavyweight-wet-amd-contender
I think a deal could come out of the blue at any stage and with little if any warning as big pharma evaluates their future options. Novartis in particular would seem to be under pressure. We don't actually know what discussions may have already occurred, but I think the CEO would want full value and big pharma would be reluctant if they believe they have alternatives. However one by one, those alternatives have gone down the gurgler.
Ann: Opthea's OPT-302 Granted Fast-Track for wet AMD, page-28
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
85.0¢ |
Change
0.025(3.03%) |
Mkt cap ! $1.055B | |||
| Open | High | Low | Value | Volume |
| 82.0¢ | 87.0¢ | 81.0¢ | $2.966M | 3.483M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 84.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 85.0¢ | 980 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| OPT (ASX) Chart |